Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04743544
Status:
UNKNOWN
Last Update Posted:
2021-02-08
First Post:
2021-02-03
Brief Title:
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Sponsor:
Organization:
Dokuz Eylul University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
2 mL of blood sample collected into an EDTA Ethylenediaminetetraacetic Acid tube for PGx analysis and another 2 mL of blood sample collected into an EDTA Ethylenediaminetetraacetic Acid tube for voriconazole TDM
Enrollment Count:
62
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 72410 |
Who Masked List: